Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Lensar Inc (LNSR)

Lensar Inc (LNSR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 37,034
  • Shares Outstanding, K 11,395
  • Annual Sales, $ 42,160 K
  • Annual Income, $ -14,380 K
  • 60-Month Beta 0.47
  • Price/Sales 0.87
  • Price/Cash Flow N/A
  • Price/Book 1.06
Trade LNSR with:

Options Overview Details

View History
  • Implied Volatility 68.99% ( -38.65%)
  • Historical Volatility 105.02%
  • IV Percentile 53%
  • IV Rank 16.48%
  • IV High 396.43% on 04/03/24
  • IV Low 4.38% on 01/17/24
  • Put/Call Vol Ratio 0.00
  • Today's Volume 59
  • Volume Avg (30-Day) 40
  • Put/Call OI Ratio 0.92
  • Today's Open Interest 1,180
  • Open Int (30-Day) 1,039

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/22
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -0.65
  • Growth Rate Est. (year over year) +153,792.31%

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.67 +21.72%
on 04/08/24
3.92 -17.09%
on 03/27/24
-0.26 (-7.41%)
since 03/22/24
3-Month
2.67 +21.72%
on 04/08/24
5.30 -38.68%
on 03/04/24
-0.28 (-7.93%)
since 01/22/24
52-Week
1.80 +80.56%
on 11/08/23
5.30 -38.68%
on 03/04/24
+0.61 (+23.11%)
since 04/21/23

Most Recent Stories

More News
LENSAR Reports Fourth Quarter and Full Year 2022 Results and Provides Business Update

LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or “the Company”), a global medical technology company focused on advanced femtosecond laser surgical solutions for the treatment of cataracts, today announced...

LNSR : 3.25 (+0.62%)
LENSAR to Report Fourth Quarter and Full Year 2022 Financial Results on Thursday, March 16, 2023

LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or “the Company”), a global medical technology company focused on advanced femtosecond laser surgical solutions for the treatment of cataracts, today announced...

LNSR : 3.25 (+0.62%)
LENSAR Announces Preliminary Fourth Quarter and Full Year 2022 Results

LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or “the Company”), a global medical technology company focused on advanced femtosecond laser surgical solutions for the treatment of cataracts, today announced...

LNSR : 3.25 (+0.62%)
LENSAR to Present at Two Upcoming Investor Conferences

LENSAR, Inc. (NASDAQ: LNSR) (“LENSAR” or “the Company”), a global medical technology company focused on advanced femtosecond laser surgical solutions for the treatment of cataracts, today announced...

LNSR : 3.25 (+0.62%)
LENSAR Reports Third Quarter 2022 Financial Results and Provides Business Update

LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or “the Company”), a global medical technology company focused on advanced femtosecond laser surgical solutions for the treatment of cataracts, today announced...

LNSR : 3.25 (+0.62%)
LENSAR to Report Third Quarter 2022 Financial Results on Wednesday, November 9, 2022

LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or “the Company”), a global medical technology company focused on advanced femtosecond laser surgical solutions for the treatment of cataracts, today announced...

LNSR : 3.25 (+0.62%)
LENSAR Announces Application for Certification of the ALLY™ Adaptive Cataract Treatment System in the EU

LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or “the Company”), a global medical technology company focused on advanced femtosecond laser surgical solutions for the treatment of cataracts, today announced...

LNSR : 3.25 (+0.62%)
First Patients Treated with LENSAR’s® ALLY™ Adaptive Cataract Treatment System

LENSAR, Inc. (NASDAQ: LNSR) (“LENSAR” or the “Company”), a global medical technology company focused on advanced femtosecond laser surgical solutions for the treatment of cataracts, today announced...

LNSR : 3.25 (+0.62%)
LENSAR Reports Second Quarter 2022 Financial Results and Provides Business Update

LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or “the Company”), a global medical technology company focused on advanced femtosecond laser surgical solutions for the treatment of cataracts, today announced...

LNSR : 3.25 (+0.62%)
LENSAR to Report Second Quarter 2022 Financial Results on Monday, August 8, 2022

LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or “the Company”), a global medical technology company focused on advanced femtosecond laser surgical solutions for the treatment of cataracts, today announced...

LNSR : 3.25 (+0.62%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Sell with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

LENSAR Inc. is a commercial-stage medical device company. It focuses on designing, developing and marketing an advanced femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. LENSAR Inc. is based in Orlando, Florida.

See More

Key Turning Points

3rd Resistance Point 3.48
2nd Resistance Point 3.40
1st Resistance Point 3.32
Last Price 3.25
1st Support Level 3.16
2nd Support Level 3.08
3rd Support Level 3.00

See More

52-Week High 5.30
Fibonacci 61.8% 3.96
Fibonacci 50% 3.55
Last Price 3.25
Fibonacci 38.2% 3.14
52-Week Low 1.80

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar